Skip to main content

Advertisement

SpringerLink
Log in

Independent Factors Associated with Recurrent Bleeding in Cirrhotic Patients with Esophageal Variceal Hemorrhage

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background, Purpose, and Methods Cirrhotic patients with acute esophageal variceal (EV) hemorrhage are characterized by high mortality and rebleeding rates. This study was conducted to investigate the independent indicators of recurrent hemorrhage in cirrhotic patients within 6 weeks after cessation of initial EV bleeding. Ninety-seven consecutive cirrhotic patients with EV bleeding, but without evidence of infection, who were admitted to our hospital between December 2005 and February 2008 were retrospectively analyzed. Among these patients, 14 patients with recurrent hemorrhage and 83 without rebleeding within 6 weeks were enrolled as the rebleeding group and non-rebleeding group, respectively. Results The incidence of infection and number of EV ligations were significantly higher in the rebleeding group than in the non-rebleeding group (P = 0.043 and 0.042, respectively). Other parameters, such as age, gender, etiology and severity of liver cirrhosis, ascites, spleen diameter, laboratory data, hepatocellular carcinoma, portal vein thrombosis, peptic ulcer disease, blood pressure, requirements of blood transfusion and differential vasoactive mediations, had no significant influence on the incidence of rebleeding. The ratio of mortality (7/14 vs. 3/83) was significantly higher in the rebleeding group (P = 0.0002), and these cases were caused by rebleeding and sepsis. The frequency of rebleeding and mortality mostly occurred within the first 2 weeks after admission. Conclusion This study provides evidence that early recurrent hemorrhage after initial EV bleeding in cirrhotic patients is significantly associated with higher incidence of bacterial infection and more numbers of EV ligations due to extensive surface area of mucosal injury and post-banding ulcers. Prevention of rebleeding and infection plays a major role in reducing the rate of mortality in cirrhotic patients with EV bleeding.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology. 1981;80:800–809.

    PubMed  CAS  Google Scholar 

  2. Burroughs AK, McCormick P, Hughes M, et al. Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Emergency control and prevention of early variceal rebleeding. Gastroenterology. 1990;99:1388.

    PubMed  CAS  Google Scholar 

  3. D’Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology. 1995;22:332–354. doi:10.1002/hep.1840220145.

    PubMed  CAS  Google Scholar 

  4. Goulis J, Armonis A, Patch D, Sabin C, Greeslade L, Burroughs AK. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology. 1998;27:1207–1212. doi:10.1002/hep.510270504.

    Article  PubMed  CAS  Google Scholar 

  5. de Franchis R. Evolving consensus in portal hypertension report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 1992;15:167–176. doi:10.1016/0168-8278(92)90044-P.

    Google Scholar 

  6. D’Amico G, Luca A. Natural history. Clinical-haemodynamic correlations. Predication of the risk of bleeding. Baillieres Clin Gastroenterol. 1997;11:243–256. doi:10.1016/S0950-3528(97)90038-5.

    Article  PubMed  CAS  Google Scholar 

  7. De Franchis R, Primignani M. Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis. 2001;5(3):645–663. doi:10.1016/S1089-3261(05)70186-0.

    Article  PubMed  Google Scholar 

  8. D’Amico G, De Franchis R, Cooperative Study Group. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology. 2003;38:599–612. doi:10.1053/jhep.2003.50385.

    Article  PubMed  Google Scholar 

  9. Siringo S, McCormick PA, Mistry P, et al. Prognostic significance of the white nipple sign in variceal bleeding. Gastrointest Endosc. 1991;37:51–55.

    Article  PubMed  CAS  Google Scholar 

  10. Ben-Ari Z, Cardin F, McCormick PA, et al. A predictive model for failure to control bleeding during acute variceal hemorrhage. J Hepatol. 1999;31:443–450. doi:10.1016/S0168-8278(99)80035-X.

    Article  PubMed  CAS  Google Scholar 

  11. Heresbach D, Bretagne JF, Raoul JL, et al. Pronostic et facteurs pronostiques de l’hémorragie par rupture de varice chez le cirrhotique àl’ère de la sclérose endoscopique. Gastroenterol Clin Biol. 1991;15:838–844.

    PubMed  CAS  Google Scholar 

  12. Bernard B, Nguyen KE, Nguyen K, et al. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology. 1999;29:1655–1661. doi:10.1002/hep.510290608.

    Article  PubMed  CAS  Google Scholar 

  13. Rimola A, Bory F, Teres J, Perez-Ayuso RM, Arroyo V, Rodes J. Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage. Hepatology. 1985;5:463–467. doi:10.1002/hep.1840050320.

    Article  PubMed  CAS  Google Scholar 

  14. Soriano G, Guarner C, Tomas A, et al. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage. Gastroenterology. 1992;103:1267–1272.

    PubMed  CAS  Google Scholar 

  15. Blaise M, Pateron D, Trinchet JC, et al. Systemic antibiotic therapy prevents bacterial infections in cirrhotic patients with gastrointestinal hemorrhage. Hepatology. 1994;20:34–38.

    Article  PubMed  CAS  Google Scholar 

  16. Pauwels A, Mostefa-Kara N, Debenes B, Degoutte E, Florent C, Levy VG. Antimicrobial prophylaxis after gastrointestinal hemorrhage for cirrhotic patients with a high risk of infection. Hepatology. 1996;24:802–806.

    PubMed  CAS  Google Scholar 

  17. Hou MC, Lin HC, Liu TT, et al. Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial. Hepatology. 2004;39:746–753. doi:10.1002/hep.20126.

    Article  PubMed  CAS  Google Scholar 

  18. Duvnjak M, Barsic N, Tomasic V, Jukic LV, Lerotic I, Pavic T. Adjusted blood requirement index as indicator of failure to control acute variceal bleeding. Croat Med J. 2006;47:398–403.

    PubMed  Google Scholar 

  19. Stiegmann GV, Goff JS. Endoscopic esophageal varix ligation preliminary clinical experience. Gastrointest Endosc. 1988;34:113–117.

    Article  PubMed  Google Scholar 

  20. D’Amico G, De Franchis R, Torri V. End-of-the-century reappraisal of the 6-week outcome of upper gastrointestinal bleeding in cirrhosis: a prospective study. Gastroenterology. 1999;116:1199.

    Google Scholar 

  21. Soderlund MI, Torngren LL. Terlipressin (triglycyl-lysine vasopressin) controls acute bleeding oesophageal varices: a double-blind, randomized, placebo-controlled trial. Scand J Gastroenterol. 1990;25:622–630. doi:10.3109/00365529009095539.

    Article  PubMed  CAS  Google Scholar 

  22. Testoni PA, Masci E, Passaretti S, et al. Comparison of somatostatin and cimetidine in the treatment of acute esophageal variceal bleeding. Curr Ther Res. 1986;39:759–766.

    Google Scholar 

  23. Sørensen TIA. Definition of death in relation to variceal bleeding. In: Burroughs AK, ed. Methodology and Reviews of Clinical Trials in Portal Hypertension: Proceedings of the International Workshop on Portal Hypertension. Excerpta Medica, Amsterdam?. New York: Oxford University Press; 1987:31–35.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Division of Gastroenterology, Taichung Veterans General Hospital, 160, Section 3, Taichung Harbor Road, Taichung, 407, Taiwan

    Shou-Wu Lee, Teng-Yu Lee & Chi-Sen Chang

  2. Department of Medicine, Chung Shan Medical University, Taichung, Taiwan

    Teng-Yu Lee & Chi-Sen Chang

Authors
  1. Shou-Wu Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Teng-Yu Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chi-Sen Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shou-Wu Lee.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, SW., Lee, TY. & Chang, CS. Independent Factors Associated with Recurrent Bleeding in Cirrhotic Patients with Esophageal Variceal Hemorrhage. Dig Dis Sci 54, 1128–1134 (2009). https://doi.org/10.1007/s10620-008-0454-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-008-0454-0

Keywords

Search

Navigation